Effects of Rosuvastatin and Aspirin on Retinal Vascular Structures in Hypercholesterolemic Patients with Low-to-Moderate Risk of Coronary Artery Disease

DiscussionFor patients with a low-to-moderate risk of CAD, we found a significant effect of rosuvastatin on retinal microvasculature, including AVR increase, venular constriction, and arteriolar dilation after 6 –12 months of treatment.Clinical Trial registrationChinese Clinical Trial Registry identifier number ChiCTR-IOR-15006664.

http://link.springer.com/10.1007/s40256-019-00330-y

Source: American Journal of Cardiovascular Drugs - February 22, 2019 Category: Cardiology Source Type: research